Clinical trial
A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma…
NCT00457782 · Kyowa Kirin Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00457782 |
|---|---|
| Title | A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma |
| Official title | A Phase I, Open-Label, Dose-escalation, Multicentre Study of KW-2478 Administered as a Single Agent Intravenously in a Consecutive Dosing Schedule in Patients With Relapsed/Refractory Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma |
| Lead sponsor | Kyowa Kirin Co., Ltd., Industry |
| Collaborators | Kyowa Hakko Kirin UK, Ltd. Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Chronic Lymphocytic Leukaemia, B-cell Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | KW-2478 |
| Enrollment | 27 |
| Start date | Apr 1, 2007 |
| Primary completion | Aug 1, 2010 |
| Completion | Jan 1, 2011 |
| First posted | Apr 6, 2007 |
| Last update posted | Apr 25, 2024 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: